Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience
2014 · BMC Gastroenterology · 31 citations
https://doi.org/10.1186/1471-230x-14-80
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
71
Papers
1.3K
Citations
19
h-index
27
i10-index
Satoshi Yamada is an academic researcher from Taisho Pharmaceutical (Japan). The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Gastric Cancer Management and Outcomes. The author has an h-index of 19, co-authored 61 publications.
ORCID: 0000-0003-1892-5696https://doi.org/10.1186/1471-230x-14-80
https://doi.org/10.1038/s41598-020-57920-z
Click to start Chat